Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
148
datasets available to search
ShareScore release 0.9.0
Dataset results
148 results for “Vemurafenib”
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
ClinicalTrials.gov study NCT03224767. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Loc
ClinicalTrials.gov study NCT02908672. IPD Sharing: Not stated. Countries: 20. Publications: 5.
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
ClinicalTrials.gov study NCT01667419. IPD Sharing: Not stated. Countries: 29. Publications: 2.
Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma
ClinicalTrials.gov study NCT03554083. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma
ClinicalTrials.gov study NCT01689519. IPD Sharing: Not stated. Countries: 19. Publications: 7.
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in B
ClinicalTrials.gov study NCT03625141. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Underlying data for Preparation and characterization of vemurafenib microemulsion-based hydrogel using ionic liquid as the oil phase
<p><strong>Underlying data for Preparation and characterization of vemurafenib microemulsion-based hydrogel using ionic liquid as the oil phase</strong></p>
Vemurafenib Plus Cobimetinib in Metastatic Melanoma
ClinicalTrials.gov study NCT02414750. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis
ClinicalTrials.gov study NCT04943198. IPD Sharing: NO. Countries: 1. Publications: 12.
Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
ClinicalTrials.gov study NCT01959633. IPD Sharing: Not stated. Countries: 1. Publications: 16.
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
ClinicalTrials.gov study NCT01826448. IPD Sharing: YES. Countries: 3. Publications: 0.
Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
ClinicalTrials.gov study NCT02036086. IPD Sharing: YES. Countries: 1. Publications: 16.
A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
ClinicalTrials.gov study NCT01673737. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
ClinicalTrials.gov study NCT05388123. IPD Sharing: NO. Countries: 1. Publications: 2.
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations
ClinicalTrials.gov study NCT02304809. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)
ClinicalTrials.gov study NCT03727763. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation
ClinicalTrials.gov study NCT03781219. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib
ClinicalTrials.gov study NCT01983124. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05019534. IPD Sharing: NO. Countries: 1. Publications: 1.
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
ClinicalTrials.gov study NCT01748149. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.